Molecules to Medicine: Pharma Trumps HIPAA?

This past week, I was jolted out of my chair by news that a Pfizer-led group plans to buy access to patient data in hospitals . My initial reaction was anger, on a variety of levels: as a researcher, as one who is increasingly wary of the reach of huge corporations, and as an individual

Read the original here:
Molecules to Medicine: Pharma Trumps HIPAA?